Dicembrini, Ilaria
Nreu, Besmir
Montereggi, Chiara
Mannucci, Edoardo
Monami, Matteo http://orcid.org/0000-0001-9349-828X
Article History
Received: 2 December 2019
Accepted: 6 January 2020
First Online: 18 January 2020
Compliance with ethical standards
:
: ID has received speaking fees from Novonordisk; CM has no conflict of interest; BN is presently employee of Novo Nordisk; FT has no conflicts of interest to declare MM has received speaking fees from Astra Zeneca, Bristol Myers Squibb, Boehringer-Ingelheim, Eli-Lilly, Merck, Novo Nordisk, Sanofi, and Novartis and research grants from Bristol Myers Squibb; EM has received consultancy fees from Merck and Novartis speaking fees from Astra Zeneca, Bristol Myers Squibb, Boehringer-Ingelheim, Eli-Lilly, Merck, Novo Nordisk, Sanofi, and Novartis and research grants from Merck, Novartis, and Takeda. All the authors approved the final version of this manuscript. Dr. Matteo Monami is the person who takes full responsibility for the work as a whole, including the study design, access to data, and the decision to submit and publish the manuscript.
: This article does not contain any studies with human participants or animals performed by any of the authors.
: For this type of article, informed consent is not necessary.